Elias A Halabi

7PUBLICATIONS
22CO-AUTHORS
Biologically active moleculesMedical molecular engineering of nucleic acids and proteinsTumour immunologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2024
γ-Butyrolactone Derivatives of MSA-2 are STING Prodrugs.

Kelton Schleyer, Elias A Halabi, Ralph Weissleder

|Apr 05, 2024
Magnetic Silica-Coated Fluorescent Microspheres (MagSiGlow) for Simultaneous Detection of Tumor-Associated Proteins.

Elias A Halabi, Isabel Gessner, Katherine S Yang

|Feb 11, 2024
Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype.

Noah Enbergs, Elias A Halabi, Anne-Gaëlle Goubet

|Oct 12, 2023
Highly Active Myeloid Therapy for Cancer.

Ina R Fredrich, Elias A Halabi, Rainer H Kohler

|Oct 09, 2023
Hybrid LNP Prime Dendritic Cells for Nucleotide Delivery.

Riddha Das, Elias A Halabi, Ina R Fredrich

|Apr 05, 2023
Light-Deactivated Fluorescent Probes (FLASH-Off) for Multiplexed Imaging.

Elias A Halabi, Ralph Weissleder

Pageof 2

Frequent Collaborators

7 joint publications

Ralph Weissleder

4 joint publications

Rainer H Kohler

3 joint publications

Hannah M Peterson

3 joint publications

Christopher S Garris